Authors
Latest:
FDA's stand on compounding is bad for R.Ph.s and patientsA compounding leader takes issue with FDA's position that compounding is the production of a new drug that needs to be approved.
Latest:
Drug prices can't depend on who's buyingIn the prescription drug market, discriminatory pricing is common for independent community pharmacies and their patients. This fall, a Federal District Court in New York will consider a critical case: Drug Mart Pharmacy Corp. et a. v. American Home Products Corp. et al. The outcome of the case may determine whether discriminatory pricing techniques are illegal.
Latest:
Retail pharmacy and the diabetes epidemicMore than 23 million Americans, close to 8 percent of the population, have diabetes. For drugstores, the medical nature of their retail business makes them the outlet of choice for shoppers purchasing diabetes products. Retail pharmacists may choose to maximize patient awareness by placing their diabetes-care display and educational literature near the pharmacy counter.
Latest:
Rx copay cards: There's an easier wayInstead of giving out cards that reduce the copay of a prescription, why not just decrease the price per bottle of medication?
Latest:
New Migraine Meds Pharmacists Need to Know AboutNew drugs for acute migraines are almost ready for prime time. Here's what you need to know.
Latest:
Pharmacy business apps can boost profitsA round-up of apps that can improve the pharmacy bottom line and help with patient care
Latest:
Pharmacy technicians face states' scrutiny, regulationKeep reading to learn about some legal roadblocks in the way of pharmacy technicians.
Latest:
Hospital pharmacists take the lead in discharge counselingAdding pharmacists to the hospital discharge process is shown to have a positive effect on combating hospital readmission rates
Latest:
Hospital pharmacists take the lead in discharge counselingAdding pharmacists to the hospital discharge process is shown to have a positive effect on combating hospital readmission rates
Latest:
MTM cuts hospital readmissionsHospital readmissions constitute one of the most significant problems in healthcare. Medication therapy management is one way to reduce the problem.
Latest:
Diabetes Patients Not Buying Supplies Due to CostsMany diabetes patients are rationing supplies, putting off purchasing them, or completely forgoing them because of costs.
Latest:
Pharmacists: Who owns your soul?Remember when hardworking coal miners "owed their souls to the company store"? Look a little closer to home and you just might find that someone you know is in a very similar spot.
Latest:
Beware of fake remedies sold as "dietary supplements"Manufacturers, promoters, and sellers of dietary supplements are prohibited by law from making claims to treat or cure illness or disease, or their symptoms. Pharmacists should encourage patients to check with medical professionals before commencing use of any dietary supplement.
Latest:
NCPA testifies at Rx drug gray market Senate hearingAt a hearing held last week about the prescription drug gray market, John Coster, PhD, RPh, senior vice president of government affairs, National Community Pharmacists Association, testified that a balanced approach was necessary to address the prescription drug shortage problem and to protect patient care.
Latest:
Diabetic test strips and state tax lawsBecause their classification is variable, the taxation of glucose test strips varies from state to state, giving rise to massive confusion and loss of revenue
Latest:
Diabetic test strips and state tax lawsBecause their classification is variable, the taxation of glucose test strips varies from state to state, giving rise to massive confusion and loss of revenue
Latest:
Pharmacists’ Public Health Role Grows as Birth Control Prescribing Authority ExpandsAn increasing number of pharmacists are now prescribing birth control, further expanding their role as public health service providers.
Latest:
Finance for pharmacists: Disability, income protection, and 401ksFinancial adviser Rick Schultenover discusses ways pharmacists can protect their financial futures.
Latest:
Mefloquine has a three-week half-lifeThe FDA recently alerted pharmacists to medication error reports about mefloquine (Lariam) prescriptions calling for 250 mg daily rather than the recommended dose of 250 mg weekly for malaria prophylaxis.
